RNA, 7SL, cytoplasmic 584, pseudogene (RN7SL584P)

RN7SL584P is a pseudogene of the 7SL RNA family, specifically identified as "RNA, 7SL, cytoplasmic 584, pseudogene"[1][2]. It represents a non-functional, typically noncoding genomic sequence derived from the 7SL RNA, an essential RNA component of the signal recognition particle (SRP) ribonucleoprotein complex[3][4]. The vast majority of 7SL RNA pseudogenes are thought to arise from reverse transcription and insertion of 7SL RNA molecules into the genome, but do not encode proteins or functional RNA[4]. Unlike genuine 7SL RNA genes, which play a critical role in protein targeting and translocation, pseudogenes like RN7SL584P do not have known biological functions or direct involvement in disease, drug interactions, or therapeutic targeting[1][4][6]. RN7SL584P is a non-coding pseudo-copy and its annotation as a "pseudogene" means it does not encode a functional product, possesses no known molecular or biological function, and is not considered a target for drugs, biomarkers, or therapeutic intervention[1][2][4]. There is no evidence in scientific databases or literature of involvement in signaling, disease, or clinical applications[1][4]. Its listing as a target is likely incorrect or irrelevant in the context of therapeutic target discovery. This entry describes a pseudogene, not a functional receptor, enzyme, transporter, or other canonical therapeutic target. "is_incorrect" is true because, while the gene symbol and alias are correct, RN7SL584P does not fit the central definition of a druggable or functionally relevant target for therapeutic development. No further structured data fields are relevant or available.

Other names

RN7SL584P